CLINICAL TRIAL

Advertisement
Jan 26 2026HEALTH

A New Hope for Duchenne Patients: ELEVIDYS Shows Promise

Duchenne muscular dystrophy is a tough disease that makes muscles weak over time. Kids with this condition often struggle with simple movements like standing up or walking. But there's some good news! A treatment called ELEVIDYS is showing positive results in a big study called EMBARK. The study lo

reading time less than a minute
Jan 22 2026HEALTH

Walking Towards Healing: A New Approach to Treating PTSD

PTSD, or Post-Traumatic Stress Disorder, is a serious condition that can affect people after they've been through a very scary or dangerous event. It can make them feel anxious, scared, or even make them avoid things that remind them of what happened. Treatments for PTSD are always evolving, and one

reading time less than a minute
Jan 20 2026HEALTH

ADHD Treatment Device Falls Short in New Study

A device approved by the FDA for treating ADHD in children has been found ineffective in a recent clinical trial. The external trigeminal nerve stimulator, which was expected to reduce ADHD symptoms, showed no significant improvement compared to a placebo. The FDA had initially approved the device

reading time less than a minute
Jan 20 2026HEALTH

Finding Strength After Cancer: A New Approach to Healing

Cancer doesn't just hurt the body; it also takes a toll on the mind. Some survivors find a silver lining in their fight, growing stronger in unexpected ways. But how can we help more people find this strength? A recent study set out to answer this question. The study focused on people who had beate

reading time less than a minute
Jan 15 2026HEALTH

Bright Hope: New Brain Treatment Offers Relief for Depression

Depression can be a heavy fog that clouds the mind and makes simple tasks feel impossible. For years, Valerie Zeko felt this fog, struggling with a condition that made her feel like her life was falling apart. She tried different antidepressants, but they either didn't work or caused more problems,

reading time less than a minute
Jan 15 2026HEALTH

A New Leader Joins the Fight Against Cancer

ViroMissile, Inc. has welcomed Michael G. Wood as their new Chief Business Officer. This move is big news for the company, which is working on a new way to fight cancer using viruses. Wood's job will be to help the company grow, find money for projects, and make important deals. Wood has a lot of e

reading time less than a minute
Jan 15 2026HEALTH

Weight Loss Drugs Get a Mental Health Clearance

The FDA has made a big change. They want to take off the suicide warning from popular weight loss drugs like Wegovy and Zepbound. This news comes after they looked at lots of data and found no link between these drugs and suicidal thoughts. These drugs, known as GLP-1, were first made to help peopl

reading time less than a minute
Jan 12 2026HEALTH

How One Study Beat the Odds: COVID-19 and Cyberattacks

The COVID-19 pandemic shook up the world of medical research. With hospitals overwhelmed and staff stretched thin, many clinical trials faced big hurdles. Some were even called off or put on hold. But not all stories were like that. The EMERGE trial, which looked at using metformin early in gestatio

reading time less than a minute
Jan 07 2026HEALTH

New Hope for Kidney Disease: The Promise of ARNIs

ARNIs, or Angiotensin Receptor-Neprilysin Inhibitors, are making waves in the medical world. They're already changing the game for heart failure patients. Now, doctors are wondering if they can do the same for people with kidney disease. Neprilysin is a substance in the body. It breaks down certain

reading time less than a minute
Jan 07 2026HEALTH

A New Hope for Tough-to-Treat Leukemia Patients

In a significant stride for medicine, a new drug combo is showing promise for people with a tough type of blood cancer. The combo, AB8939 plus venetoclax, is showing positive results in four patients who had run out of other options. These patients had a complex form of acute myeloid leukemia (AML),

reading time less than a minute